Oncology and Hematology - Global Oncology Academy

449-464 of 595

Addressing Health Equity in Genitourinary Cancer Clinical Trials
Addressing Health Equity in Genitourinary Cancer Clinical Trials
Project Oncology®
Addressing Health Equity in Genitourinary Cancer Clinical Trials
An Exploration of Current and Emerging Therapies for mCRPC
An Exploration of Current and Emerging Therapies for mCRPC
Project Oncology®
An Exploration of Current and Emerging Therapies for mCRPC
NSCLC Care: Evaluating Durvalumab in the First-Line Setting
NSCLC Care: Evaluating Durvalumab in the First-Line Setting
Project Oncology®
NSCLC Care: Evaluating Durvalumab in the First-Line Setting
- Jacob Sands, MD
- Liza Villaruz, MD
Inflammatory Breast Cancer: A New Scoring System Proposed
Inflammatory Breast Cancer: A New Scoring System Proposed
Project Oncology®
Inflammatory Breast Cancer: A New Scoring System Proposed
- Filipa Lynce, MD
SABCS 2023: A Look into New Research for Inflammatory Breast Cancer
SABCS 2023: A Look into New Research for Inflammatory Breast Cancer
Project Oncology®
SABCS 2023: A Look into New Research for Inflammatory Breast Cancer
- Filipa Lynce, MD
A Look at What’s New in Invasive Lobular Carcinoma
A Look at What’s New in Invasive Lobular Carcinoma
Project Oncology®
A Look at What’s New in Invasive Lobular Carcinoma
- Pavani Chalasani, MD, MPH
- Jason A. Mouabbi, MD
Early Breast Cancer Care: Omitting Radiation Therapy Linked to Less Fear of Recurrence
Early Breast Cancer Care: Omitting Radiation Therapy Linked to Less Fear of Recurrence
Project Oncology®
Early Breast Cancer Care: Omitting Radiation Therapy Linked to Less Fear of Recurrence
The Evolving Landscape of Targeted Therapies for Non-Small Cell Lung Cancer
The Evolving Landscape of Targeted Therapies for Non-Small Cell Lung Cancer
Project Oncology®
The Evolving Landscape of Targeted Therapies for Non-Small Cell Lung Cancer
Antibody-Drug Conjugates: An Emerging Approach in NSCLC Treatment
Antibody-Drug Conjugates: An Emerging Approach in NSCLC Treatment
Project Oncology®
Antibody-Drug Conjugates: An Emerging Approach in NSCLC Treatment
Staying Up to Date on Advancements in Triple-Negative Breast Cancer Care
Staying Up to Date on Advancements in Triple-Negative Breast Cancer Care
Project Oncology®
Staying Up to Date on Advancements in Triple-Negative Breast Cancer Care
Challenging the Standard of Care in NSCLC: Findings from the TROPION-Lung01 Study
Challenging the Standard of Care in NSCLC: Findings from the TROPION-Lung01 Study
Project Oncology®
Challenging the Standard of Care in NSCLC: Findings from the TROPION-Lung01 Study
The Role of PARP Inhibitors in Metastatic Breast Cancer
The Role of PARP Inhibitors in Metastatic Breast Cancer
Project Oncology®
The Role of PARP Inhibitors in Metastatic Breast Cancer
Navigating NUT Carcinoma: Diagnosis and Treatment Strategies
Navigating NUT Carcinoma: Diagnosis and Treatment Strategies
Project Oncology®
Navigating NUT Carcinoma: Diagnosis and Treatment Strategies
- Jacob Sands, MD
- Jia Luo, MD
Diving into the Efficacy & Tolerability of mBC Treatment
Diving into the Efficacy & Tolerability of mBC Treatment
Project Oncology®
Diving into the Efficacy & Tolerability of mBC Treatment
- Pavani Chalasani, MD, MPH
- Colleen Bohnenkamp, PharmD, BCPS, BCOP
Reducing the Rise of Uterine Cancer in the United States
Reducing the Rise of Uterine Cancer in the United States
Project Oncology®
Reducing the Rise of Uterine Cancer in the United States
- Charles Turck, PharmD, BCPS, BCCCP
- Richard T. Penson, MD, MRCP
Study Shows Importance of Comprehensive Genomic Profiling for NSCLC
Study Shows Importance of Comprehensive Genomic Profiling for NSCLC
Project Oncology®
Study Shows Importance of Comprehensive Genomic Profiling for NSCLC
- Vivek Subbiah, MD

29/11